SCAPIS - the Largest Cardiovascular and Pulmonary Research Program in Sweden. The Swedish Cardiopulmonary Bioimage Study (SCAPIS) combines the use of new imagine technologies, advances in large-scale 'comics' and epidemiological analyses to extensively characterize a Swedish cohort of 30 000 men and women aged between 50 and 64 years. SCAPIS, Swedish CArdioPulmonary bioImage Study, is a population study around cardiovascular, epidemic and genetic research, initiated by Swedish researchers in 2007. A pilot study was conducted in 2012 to ensure that the population study was possible to implement, and in 2014, the major SCAPIS study was initiated. SCAPIS – Swedish CArdioPulmonary bioImage Study Projektet har genomförts på sex universitetsorter i landet och har samlat in data och prover från totalt 30 000 personer i Sverige. I Uppsala är det Akademiska sjukhuset och Uppsala universitet som ansvarar för SCAPIS. SCAPIS, Swedish CArdioPulmonary bioImage Study, är en befolkningsstudie kring kardiovaskulär, epidemisk och genetisk forskning som initierades av svenska forskare 2007.
- Naturvetenskapliga begrepp
- Maxi grand samarkand växjö
- Oecd code ga 430
- Systemet gällivare öppettider
- Xxl orebro cykel
- Företagets olika intressenter
Between 2013 and 2018, 30,154 men and women The Swedish cardiopulmonary bio-image study (SCAPIS) combines the use of new imaging technologies, advances in large-scale “omics,” and epidemiological analyses to extensively characterize a Swedish cohort of 30,000 men and women aged between 50 and 64 years . Recruitment will be completed at the end of 2018. The study population for this investigation originated from the Swedish CArdioPulmonary bioImage Study (SCAPIS) pilot trial, which was conducted at the Sahlgrenska University Hospital in Gothenburg, Sweden in 2012 (Bergstrom et al., 2015b). The SCAPIS cohort from the Linköping site for whom an additional sampling of hair was made constitute the control group in this study (data collected 2015–2018). The Swedish CArdioPulmonary bioImage Study, SCAPIS, is a nationwide, open-access, population-based cohort for the study of cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD).
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift 2 Apr 2021 The SCAPIS study is a Swedish nationwide population-based cohort mainly designed to research cardiovascular and chronic obstructive 14 Nov 2020 The SCAPIS project is a collaborative effort of 6 universities in Sweden.
“The SCAPIS study will provide excellent opportunities to identify new associations between biomarkers for disease in blood samples collected here in the last 30 years with the subsequent findings on lung and heart disease,” says Anders Blomberg, principal researcher at SCAPIS and professor at the Department of Public Health and Clinical Medicine at Umeå University. SCAPIS is a Swedish population study that will recruit and study the heart and lung status of 30,000 randomly selected women and men of the ages 50-64. The purpose is to be able to identify individual risks for stroke, COPD, sudden cardiac arrest, myocardial infarction and other heart diseases.
The objective of the SCAPIS study is to be able to identify individual risks of, SCAPIS is supported by the Swedish Heart and Lung Foundation, the Knut and Alice Wallenberg Foundation, the Swedish Research Council and VINNOVA.
SCAPIS, Swedish CArdioPulmonary bioImage Study, är en befolkningsstudie kring kardiovaskulär, epidemisk och genetisk forskning som initierades av svenska forskare 2007. En första pilotstudie gjordes 2012 för att säkerställa att befolkningsstudien var möjlig att genomföra och 2014 startades den stora SCAPIS-studien. Read more about the SCAPIS study and request data access at www.scapis.org. INSAMLINGSKONTO. Plusgiro 90 91 92-7; Bankgiro 909-1927; Swish 90 91 92 7; KONTAKT. Hjärt
The aim of the Swedish CArdioPulmonary bioImage Study (SCAPIS) is to predict and prevent cardiovascular disease (CVD) and COPD. SCAPIS will recruit and investigate approximately 30,000 men and women aged 50 to 64 years with detailed imaging and functional analyses of the cardiovascular and pulmonary systems.
Lönekrav 2021
This study on microcirculatory function was an add-on study at the Linköping site within the multicenter study, SCAPIS. The rationale and methodology of SCAPIS have been described previously . The study participants were randomly sampled from the population registry, including men and women between 50 and 65 yr living in Linköping, Sweden. 2020-12-31 The SCAPIS study is a Swedish multicentre collaboration between six host universities and university hospitals, and considerable time and resources have been invested to enable the completion of the study including more than 30,000 participants. SCAPIS is a national project in Sweden and stands for Swedish CardioPulmonary bioImage Study.
A total of 30,154 men and women in Sweden, from 50 to 64 years old, have been recruited and investigated with detailed imaging and functional analyses of the cardiovascular and pulmonary systems. The Swedish SCAPIS study of more than 30,000 middle-aged adults found approximately 40% had atherosclerosis, underscoring the importance of early detection of coronary artery disease, according to researchers presenting their findings Nov. 13 during AHA 2020. The study also found success with a personalized screening questionnaire to identify individuals at higher risk for cardiovascular disease. The Swedish CArdioPulmonarybioImage Study (SCAPIS) combines the use of new imaging technologies, advances in large-scale 'omics' and epidemiological analyses to extensively characterize a Swedish cohort of 30 000 men and women aged between 50 and 64 years. The Swedish Cardiopulmonary Bioimage Study (SCAPIS) combines the use of new imagine technologies, advances in large-scale 'comics' and epidemiological analyses to extensively characterize a Swedish cohort of 30 000 men and women aged between 50 and 64 years. SCAPIS, Douglas continued, is testing a tiered testing proposal that predicts risk by a definition of anatomic risk based on the presence of any coronary disease in four or more segments.
Växjö tingsrätt förhandlingar
During the data analysis phase of SCAPIS, some research projects were defined and performed on interim material (n≈15,000). The interim research questions were defined by the SCAPIS Steering Committee. One of the main purposes of the interim studies were to gain knowledge on data quality and handling. SCAPIS står för Swedish CardioPulmonary bioImage Study och är ett världsunikt forskningsprojekt inom hjärta, kärl och lunga och drivs av Sahlgrenska Universitetssjukhuset, Gothia Forum och Göteborgs universitet i samarbete med Hjärt-Lungfonden. SCAPIS, the Swedish CardioPulmonary bioImage Study, är den hittills största svenska studien inom området hjärta, kärl och lunga, vilken inkluderar 30.000 män och kvinnor (50-64 år) från olika regioner i Sverige. Datainsamlingen avslutades under 2018.
A The Swedish SCAPIS study of more than 30,000 middle-aged adults found approximately 40% had atherosclerosis, underscoring the importance of early detection of coronary artery disease, according to researchers presenting their findings Nov. 13 during AHA 2020. The Swedish Cardiopulmonary Bioimage Study (SCAPIS) combines the use of new imagine technologies, advances in large-scale 'comics' and epidemiological analyses to extensively characterize a Swedish cohort of 30 000 men and women aged between 50 and 64 years.
Viltforvaltning kommune
eric andersson
adecco usa
medlemslan unionen
volvo v90 t8 bransleforbrukning
akutmottagningen ljungby
martin arvidson tele2
This study is the first report from SCAPIS, a collaborative project between six Swedish universities with the vision statement: to reduce the risk of cardiovascular and respiratory diseases for The SCAPIS study is a Swedish nationwide population-based cohort mainly designed to research cardiovascular and chronic obstructive pulmonary diseases. Between 2013 and 2018, 30,154 men and women The Swedish cardiopulmonary bio-image study (SCAPIS) combines the use of new imaging technologies, advances in large-scale “omics,” and epidemiological analyses to extensively characterize a Swedish cohort of 30,000 men and women aged between 50 and 64 years . Recruitment will be completed at the end of 2018. The study population for this investigation originated from the Swedish CArdioPulmonary bioImage Study (SCAPIS) pilot trial, which was conducted at the Sahlgrenska University Hospital in Gothenburg, Sweden in 2012 (Bergstrom et al., 2015b). The SCAPIS cohort from the Linköping site for whom an additional sampling of hair was made constitute the control group in this study (data collected 2015–2018).